Severity
Moderate
CPSC recall · Reported December 23, 2020
Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poison…
Gsk Consumer Healthcare, of Warren, N.j. recalled This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migrain… - a moderate-severity action.
GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant P… was recalled by Gsk Consumer Healthcare, of Warren, N.j. in December 23, 2020. Reason: Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, c…. Remedy: Consumers should immediately store the recalled Excedrin bottles out of sight and reach o…. Verify recall #21057 with the CPSC before acting.
The recall
Gsk Consumer Healthcare, of Warren, N.j. issued this moderate-severity CPSC recall-Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, c….
Sourced from official CPSC enforcement records. Verify recall #21057 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This CPSC action (record #21057) was formally reported on December 23, 2020. It is classified under Moderate severity, with a current status of Active. Gsk Consumer Healthcare, of Warren, N.j. is listed as the recalling firm. Federal records list the affected scope as About 433,600.
The documented reason for this recall is: Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substanc… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bot… - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
About 433,600
Related Recalls
6
0 from same agency
This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued.
Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).
Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 21057 |
| Date reported | December 23, 2020 |
| Date initiated | December 23, 2020 |
| Recalling firm | Gsk Consumer Healthcare, of Warren, N.j. |
| Affected scope | About 433,600 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the…
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported December 23, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.